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Vibrio vulnificus hemolysin, purified by quantitative isoelectric focusing, was used to prepare rabbit and goat
anti-hemolysin. The resulting antibodies were used as capture and detector antibody reagents in a sandwich
enzyme-linked immunosorbent assay (ELISA) to detect V. vulnificus in environmental samples. By this tech-
nique, 4 laboratory-maintained V. vulnificus strains and 33 environmental V. vulnificus isolates were detected.
Also, the technique distinguished five other Vibrio species from V. vulnificus, and when it was used in
combination with colistin-polymyxin-cellobiose agar, 31 non-V. vulnificus isolates were excluded. This sandwich
ELISA compared favorably with the current Food and Drug Administration standard immunoassay in con-
firming presumptive V. vulnificus colonies from environmental specimens: oysters, sediment, and seawater.
Among 340 presumptive V. vulnificus colonies, the sandwich ELISA detected 95% of the confirmed V. vulnificus
colonies. Equally important, the technique correctly distinguished 99% of the non-V. vulnificus colonies. The
sandwich ELISA offers time-saving and labor-saving advantages over the currently accepted immunoassay.
The American oyster (Crassostrea virginica) industry is
threatened because of public health concerns over Vibrio vulni-
ficus in raw oysters. This gram-negative bacterium causes se-
vere illness and mortality in susceptible consumers. Represen-
tative isolates can be confirmed biochemically as V. vulnificus
by a standard identification scheme that takes many days (36);
however, many phenotypic traits are variable (24, 28, 42).
There is much research toward developing species-specific im-
munoassays to detect V. vulnificus in clinical and environmen-
tal samples (5, 23, 24, 31, 32, 35).
An antigenic protein, V. vulnificus hemolysin (VVH), is pro-
duced in maximal amounts at the mid- to late-exponential
growth phase (8, 15, 25, 37). VVH is apparently specific to V.
vulnificus. A radiolabeled probe to the VVH gene provides
specific confirmation of both environmental and clinical iso-
lates of V. vulnificus (12, 21, 43). Hemolysin production has
been reported in all V. vulnificus isolates tested by numerous
investigators, including 12 isolates tested by Johnson and Calia
(11), 44 isolates tested by Kaysner et al. (12), 16 isolates tested
by Morris et al. (21), 33 isolates tested by Morris et al. (22), 16
isolates tested by Okada et al. (25), and 40 isolates tested by
Tison and Kelly (38).
This research seeks to (i) produce reagent antibodies to
VVH, (ii) develop a sandwich enzyme-linked immunosorbent
assay (ELISA) for VVH to detect V. vulnificus isolates, and
(iii) evaluate the sandwich ELISA as a method for detection
and enumeration of V. vulnificus in oysters and other environ-
mental specimens.
MATERIALS AND METHODS
V. vulnificus isolates. V. vulnificus 27562, the type strain, was obtained from the
American Type Culture Collection, Rockville, Md.; strain E4215 was obtained
from the Centers for Disease Control and Prevention, Atlanta, Ga.; and strain
1001 was obtained from Louisiana State University, Baton Rouge. The Depart-
ment of Marine Biology, Texas A&M University at Galveston, provided strain
4916 and other environmental presumptive V. vulnificus isolates.
Stock cultures were grown on Columbia agar plates overnight at 378C and
collected with 0.85% saline solution. Decimal dilutions were measured for A690
and spread plated on heart infusion agar to obtain a standard concentration
curve for each of three strains (27562, E4215, and 1001) of the bacteria to
estimate subsequent inoculum concentrations of V. vulnificus.
Preparation and purification of VVH. The VVH from V. vulnificus E4215 was
prepared and purified by published methods (8, 14) with the following modifi-
cations. Culture medium was the filtrate from heart infusion broth prepared by
ultrafiltration in a TCF 10 stirred-cell unit equipped with a YM10 membrane
(Amicon, Inc., Beverly, Mass.). The Sephadex G-75 gel filtration step was omit-
ted because of the inefficiency of this procedure observed in preliminary exper-
iments. Also, 0.1 mM EDTA (tetrasodium salt) was included in the buffers to
chelate potentially contaminating heavy metals (6) and improve the stability of
the VVH.
Protein concentrations were estimated by the Bradford method with bovine
gamma globulin as the standard (2). Samples were assayed for microplate he-
molysis by using serial twofold sample dilutions in flat-bottom microassay plates
and an equal volume of 0.7% sheep erythrocyte suspension in phosphate-buff-
ered saline (PBS; 0.02 M Na2HPO4, 0.15 M NaCl [pH 7.4]) containing 0.1%
bovine serum albumin (15, 41, 44). The microplate was incubated for 1 h at 378C
(41) and then monitored for A690 on a microplate reader (44).
Vertical-slab sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) was performed by the method of Laemmli (16) with a Protean II
electrophoresis cell (Bio-Rad, Richmond, Calif.). For reduced VVH analysis, 20
mg of VVH was mixed with sample buffer containing 5% b-mercaptoethanol and
boiled for 2 min. For nonreduced VVH analysis, VVH was mixed with sample
buffer without reducing agent and without heat denaturation. Following SDS-
PAGE, the separated protein bands were transferred to 0.2-mm-pore-size nitro-
cellulose paper with a Trans-Blot electrophoretic transfer cell (Bio-Rad). Be-
tween each step of the Western immunoblot development, the paper was washed
three times in washing solution, consisting of 0.01 M Tris and 0.5 M NaCl (pH
7.5) containing 0.1% Tween 20 (TBS-T). Nonspecific binding was blocked for 1
h at room temperature in blocking solution, consisting of TBS-T containing 1%
nonfat dry milk (Carnation, Los Angeles, Calif.) and 0.1% normal goat serum.
The blot was developed by successive 2-h incubations at room temperature with
detector antibody (rabbit whole serum anti-VVH) diluted 1:500 in blocking
solution and developer antibody (alkaline phosphatase-conjugated goat anti-
rabbit immunoglobulin G [IgG] [whole-molecule specific; Bio-Rad]) diluted
1:1,500 in blocking solution. Bound conjugate was observed by incubation for 8
min at room temperature in the substrate 5-bromo-4-chloro-3-indolyl phosphate
with nitroblue tetrazolium salt solution (BCIP/NBT substrate kit; Zymed, South
San Francisco, Calif.), and the reaction was stopped with water washes.
Preparation of reagent antibodies. Two New Zealand White rabbits were
initially immunized subcutaneously at 568C for 30 min with heat-inactivated
VVH at 5 mg per rabbit and an equal volume of Freund’s complete adjuvant
(FCA). Over the next 18 months, subsequent booster immunizations included
Freund’s incomplete adjuvant (FIA) with 5 mg of heat-inactivated VVH (four
times) and 25 mg of active VVH (twice). One Nubian-mix goat was initially
immunized intramuscularly with 50 mg of active VVH with an equal volume of
FCA. At monthly intervals, subsequent booster immunizations included FIA
with 50 mg of active VVH (three times).
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For monoclonal antibody production, four female BALB/c mice were initially
immunized subcutaneously with FCA and heat-inactivated VVH at levels rang-
ing from 1 to 25 mg per mouse. The VVH was inactivated for primary immuni-
zation to avoid the lethal effects of active VVH on mice (8, 26, 30). Subsequent
booster immunizations included FIA with either heat-inactivated or active VVH
and either subcutaneous or intraperitoneal routes of administration. At 3 days
prior to hybridoma fusions, animals were given a final intravenous boost of either
1 mg of heat-inactivated VVH or 0.3 mg of active VVH diluted in PBS. Spleno-
cytes from primed mice were fused to myeloma cells (SP2/0-Ag14) (American
Type Culture Collection) by a standard fusion protocol with 50% polyethylene
glycol (molecular weight, ca. 1,000 Sigma, St. Louis, Mo.) (4). Hybridomas were
selected with hypoxanthine-aminopterin-thymidine selection medium (9).
Polyclonal IgG was purified from rabbit and goat sera by a two-step procedure:
affinity chromatography with CM Affi-Gel Blue (Bio-Rad) followed by 45%
saturated ammonium sulfate precipitation. Ammonium sulfate was removed
from the IgG fraction by dialysis against PBS.
Polyclonal sera, purified IgG, and hybridoma supernatants were screened for
reactivity with VVH by an antibody capture ELISA. Reagents for the antibody
capture ELISA were used at 50 ml per well unless otherwise noted. The VVH
was diluted to 5 mg/ml in ELISA coating buffer (0.1 M Na2CO3 [pH 9.6]) and
added to each well of polyvinyl chloride microplates for overnight coating at
room temperature. Between each subsequent ELISA step, microplates were
washed three times in TBS-T washing solution. The plates were blocked by
adding 200 ml of blocking solution (TBS-T containing 1.0% nonfat dry milk) and
incubating for 1 h at 378C. Serial twofold dilutions of test antibody sample in
blocking solution were added to wells and incubated for 90 min at 378C. Enzyme-
conjugated developer antibody, diluted in blocking solution, was incubated for 1
h at 378C. Goat antibodies were developed with 1:2,500-diluted horseradish
peroxidase-conjugated rabbit anti-goat IgG (whole-molecule specific) (Cappel,
Cochranville, Pa.). Rabbit antibodies were developed with 1:500-diluted alkaline
phosphatase-conjugated goat anti-rabbit IgG (whole-molecule specific) (Bio-
Rad). Mouse antibodies were developed with 1:2,000-diluted alkaline phos-
phatase-conjugated goat anti-mouse IgG (whole-molecule specific; Sigma).
Bound alkaline phosphatase conjugate was observed by adding substrate so-
lution (1 mg of p-nitrophenyl phosphate [Zymed] per ml dissolved in 0.1 M
2-amino-2-methyl-1,3-propanediol [pH 10.3]). Following a 20-min incubation at
room temperature, the wells were measured for A405.
Bound horseradish peroxidase conjugate was observed by adding 100 ml of
substrate solution (3,39,5,59-tetramethylbenzidine [TMB Microwell Peroxidase
Substrate System; KPI, Gaithersburg, Md.]) to each well. Following an 8-min
incubation at room temperature, the reaction was stopped by adding 100 ml of 1.0
M H3PO4 to each well, and wells were measured for A450.
Sandwich ELISA for purified VVH. Reagents for the sandwich ELISA for
purified VVH were used at 100 ml per well unless otherwise noted. Plates were
coated overnight at room temperature with capture antibody (rabbit IgG anti-
VVH) diluted to 7.5 mg/ml in ELISA coating buffer. Between each ELISA step,
microplates were washed four times in TBS-T washing solution. The plates were
blocked with 200 ml of blocking solution (TBS-T containing 5.0% nonfat dry
milk) for 2 h at 378C. Triplicate samples of 0, 1.56, 3.12, 6.25, 12.5, 25, 50, and 100
ng of VVH diluted in antibody diluent (TBS-T containing 1.0% nonfat milk and
0.1% normal rabbit serum) were added, and the plate was incubated for 1 h at
378C. Detector antibody (goat IgG anti-VVH, diluted 1:200 in antibody diluent)
was added, and the mixture was incubated for 1 h at 378C. Developer antibody
(horseradish peroxidase-conjugated rabbit anti-goat IgG, diluted 1:2,500 in an-
tibody diluent) was added, and the mixture was incubated for 1 h at 378C. Bound
conjugate was observed by adding TMB substrate solution as stop solution and
measuring the wells for A450 as described above.
Adsorption to decrease nonspecific ELISA background. Preliminary experi-
ments revealed that some non-V. vulnificus species would give ELISA signals
approaching those of positive V. vulnificus cultures. For reducing the nonspecific
background ELISA signal, an acetone powder extract was made from a whole-
cell bacterial culture by previously described methods (9). Pseudomonas aerugi-
nosa was chosen because of the high sandwich ELISA signal it produced in pure
culture and the likelihood that pseudomonads will contaminate environmental
samples (7, 17, 18, 33). The acetone powder extract was added to 0.5-ml aliquots
of the capture antibody and detector antibody in 10- and 25-mg amounts, re-
spectively. Following a 30-min incubation at 378C, with agitation at 100 rpm, the
supernatants were collected by centrifugation (15,0003 g for 10 min at 48C). The
detector antibody supernatant was retreated with another 25 mg of the acetone
powder extract in the same manner. The resulting adsorbed capture and detector
antibody supernatants were used in subsequent sandwich ELISAs on the envi-
ronmental specimens and presumptive V. vulnificus colonies.
Sandwich ELISA for VVH to detect V. vulnificus colonies. V. vulnificus 27562,
E4125, and 1001 were grown overnight at 378C on modified colistin-polymyxin
B-cellobiose (CPC) agar (18, 35). Sandwich ELISA plates were prepared by
coating and blocking as described previously except that the once-adsorbed
capture antibody, rabbit IgG anti-VVH, was used at 3.5 mg/ml. Following wash-
ing, 100 ml of alkaline peptone water (APW [pH 8.5]) (7) was added to each well.
Colonies of the three V. vulnificus strains were individually inoculated into three
replicate wells in each of five replicate capture antibody-coated ELISA plates.
The plates were incubated for 3, 4, 5, 6, and 24 h, respectively. The sandwich
ELISA was then completed as described above, except that immediately follow-
ing the in-plate bacterial growth, plates were washed a total of six times and the
detector antibody was the twice-adsorbed goat IgG anti-VVH.
A total of 4 laboratory-maintained V. vulnificus strains, 50 presumptive V.
vulnificus isolates, 7 non-V. vulnificus Vibrio species, and 7 unrelated gram-
negative bacteria were tested for V. vulnificus identity confirmation by both the
sandwich ELISA and Food and Drug Administration (FDA) standard immuno-
assay. The unrelated gram-negative bacteria were selected because they were
frequently included in reports on common aquatic flora (7, 17, 18, 33).
Environmental specimens. Three oyster reef sites in Galveston Bay were
chosen for specimen collection. The reefs were identified as Sammy’s Reef, Deer
Island Reef, and Confederate Reef (39). In November 1993, oysters (C. vir-
ginica), sediment, and seawater were collected from all three sites. The seawater
temperature at all sites was 168C.
Oysters were scrubbed under running tap water and rinsed with sterilized
water before being shucked. A 100-g sample of oyster was added to a 100-ml
volume of sterilized PBS (0.02 M Na2HPO4, 0.15 M NaCl [pH 7.4]) and blended
at high speed for 90 s. A 2-ml aliquot of this homogenate was diluted with 8 ml
of PBS to make the 1021 dilution. Serial decimal dilutions (1 ml added to 9 ml
of PBS) were continued through the 1023 dilution. From each of the 1021
through 1023 dilution tubes, 1-ml aliquots were inoculated into three replicate
tubes containing 10 ml of APW for use in the three-tube most-probable-number
(MPN) determination procedure. Aliquots (2 ml) of the original homogenate
were inoculated into each of three replicate tubes containing 40 ml of APW to
serve as the 1020 tubes for the MPN procedure. Excess APW diluent in the 1020
tubes served to dilute organic debris and bactericidal factors of the oyster ho-
mogenate (10, 27).
Sediment samples were drained of excess water, and 10 g (wet weight) of each
sample was vigorously mixed with 10 ml of PBS. The resultant slurry was serially
diluted and inoculated into the APW tubes in the same manner as described for
oyster samples. Seawater samples were also serially diluted in PBS and inocu-
lated in 10-ml APW tubes in the three-tube MPN pattern.
Following incubation for 12 to 14 h at 378C, the APW tubes were examined for
turbidity indicative of bacterial growth. One loopful from the top 1 cm of turbid
APW tubes was streaked onto modified CPC agar (7). The CPC plates were
incubated for 18 to 24 h at 408C and then examined for the presence of V.
vulnificus-like growth. Typical V. vulnificus growth on CPC agar appeared as flat,
yellow colonies (due to the fermentation of the cellobiose) ca. 2 mm in diameter
(7). Two presumptive V. vulnificus colonies were collected from each CPC agar
plate and inoculated into individual precoated and preblocked sandwich ELISA
plate wells containing 100 ml of APW. Following a 4-h incubation at 378C, 25 ml
of the culture from each well was transferred individually into a separate ELISA
plate for use in an FDA standard immunoassay for comparison purposes. The
sandwich ELISA was completed as described above, while the FDA standard
immunoassay (7, 35) was modified to enhance the specific ELISA signal. Incu-
bations were done at 378C instead of the published room temperature. Also,
nonspecific binding was reduced by diluting antibodies in blocking solution
instead of PBS only.
The MPN estimate of V. vulnificus per milliliter of seawater or per gram of
oyster or sediment was calculated from the number of turbid tubes later pro-
ducing confirmed V. vulnificus growth on the selective agar. A published MPN
determination table was used (1).
Statistical analysis. The standard absorbance curves for inoculum estimation
were analyzed by simple linear regression line techniques (19). Sandwich ELISAs
were compared with the FDA standard immunoassay by a chi-square test for
goodness of fit (29).
RESULTS AND DISCUSSION
Preparation and purification of VVH. Preliminary attempts
at purification of VVH by isoelectric focusing had been unsuc-
cessful because of the high lability of the protein when adjacent
to the anode and cathode solutions. This problem was over-
come by loading the sample manually (instead of with a gra-
dient-forming apparatus), with the sample solution segregated
from the electrode solutions (40). The total yield of VVH was
ca. 1 mg of purified VVH produced per batch. Highly purified
VVH showed good stability when stored at 2708C and was
inactivated by treatment at 568C for 30 min, consistent with
previous reports (8, 14).
SDS-PAGE of highly purified VVH under nonreducing con-
ditions revealed only one protein band, with an estimated
molecular weight range of 50,000 to 60,000 (data not shown).
Western blotting results showed that the highly purified intact
protein and its reduced, heat-denatured components were re-
active toward the polyclonal serum (Fig. 1). The molecular
weight of the VVH could not be estimated by Western blot












because of the relative inaccuracy of the prestained molecular
weight markers.
Preparation of polyclonal antibodies. Antibody titers in the
rabbits remained low until active VVH was used as the booster
immunogen. Following boosts with active VVH, titers reached
1:16,000. Because of the apparent increased immunogenicity
of the active VVH, all immunizations in the goat were per-
formed with the native protein. Three total immunizations
were required to achieve a titer of 1:4,000. The purified rabbit
IgG and goat IgG anti-VVH had equivalent ELISA titers to
their original whole-serum counterparts.
Sandwich ELISA for purified VVH. Incubation times for
detector and developer steps were standardized at 1 h in con-
sideration of signal quality and time efficiency. The limit of
detection was 3.12 ng of VVH, with saturation achieved at 50
ng (Fig. 2).
Sandwich ELISA for VVH to detect V. vulnificus colonies.
Colony selection from presumptive V. vulnificus colonies re-
quired more than 3 h for sandwich ELISA detection of VVH
production (Table 1). Performing the test cultures in the cap-
ture antibody-coated wells led to positive ELISA results even
before turbidity development. The growth period of the assay
was subsequently standardized at 4 h, but plates could still be
processed after overnight incubation if necessary for conve-
nience.
This sandwich ELISA correctly detected a total of 4 labora-
tory-maintained V. vulnificus strains and 33 environmental V.
vulnificus isolates (Table 2). These isolates were confirmed by
the FDA standard immunoassay. While the adsorption steps
with acetone powder extracts were helpful in decreasing back-
ground signals, weakly positive signals were still observed for
four non-V. vulnificus species (Acinetobacter calcoaceticus,
Achromobacter icthyodermis, Aeromonas hydrophila, and P.
aeruginosa) and four unknown environmental isolates. These
signaling non-V. vulnificus species were easily excluded by their
growth pattern on CPC agar (either no growth or cellobiose-
negative growth). Other Vibrio species (V. parahaemolyticus, V.
alginolyticus, V. anguillarum, and V. cholerae serogroup O139)
and unrelated bacteria were negative on the sandwich ELISA.
Environmental specimens. In conjunction with the CPC se-
lective agar, the sandwich ELISA results compared favorably
with the FDA standard immunoassay when used with the en-
vironmental specimens (Table 3). A total of 340 presumed V.
vulnificus colonies were tested, of which 96 were confirmed as
V. vulnificus growth by the FDA standard immunoassay. The
sandwich ELISA correctly detected V. vulnificus growth in 91
of these 96 colonies; i.e., it had a 95% sensitivity. The speci-
ficity of the sandwich ELISA was 99%, with 242 of 244 colonies
correctly distinguished as non-V. vulnificus. The positive pre-
dictive value of the sandwich ELISA was 98%, with 91 of the
93 positive results being correct. The negative predictive value
FIG. 1. Western blot of VVH. Lanes: 1 and 4, prestained molecular weight
markers (Bio-Rad); 2, VVH (nonreduced); 3, VVH (heat denatured under
reducing conditions). Molecular weights (in thousands) are shown at the sides.
FIG. 2. Limits of detection of VVH by sandwich ELISA. Symbols: F, raw
data;s, mean (n 5 3).
TABLE 1. Sandwich ELISA confirmation of colony isolates
by V. vulnificus strain and incubation time
Incubation
time (h)
No. of positive wellsa for V. vulnificus strain
27562 E4215 1001
3 1 3 3
4 2 3 3
5 3 3 3
6 3 3 3
24 3 3 3
a No. of positive wells out of three replicates.
TABLE 2. Bacterial species and isolates tested by
CPC agar and sandwich ELISA







Clinical isolates ATCC 27562, E4215,
1001, 4916
1 1
Environmental isolates (33 total) 1 1
Vibrio parahaemolyticus isolate S1 1 2
Vibrio parahaemolyticus ATCC 17802 and
isolates S2 and S3
2 2
Vibrio alginolyticus NG 2
Vibrio anguillarum NG 2
Vibrio cholerae serogroup O139 2 2
Acinetobacter calcoaceticus NG (1)
Achromobacter icthyodermis NG (1)
Aeromonas hydrophila 2 (1)
Aeromonas salmonicida NG 2
Edwardsiella ictaluri NG 2
Pseudomonas aeruginosa 2 (1)
Escherichia coli NG 2
Unknown environmental isolates (13 total) 1 2
Unknown environmental isolates (4 total) 2 (1)
a Symbols: 1, yellow colonies (cellobiose positive); 2, Nonyellow colonies
(cellobiose negative); NG, no growth on CPC agar; (1), Weakly positive ELISA
signal.












was also 98%, with 242 of the 247 negative results being cor-
rect. Statistical analysis by the chi-square test for goodness of
fit showed that the two tests gave similar results (P , 0.01).
When MPN procedures were applied, the day 3 sandwich
ELISA gave identical V. vulnificus enumeration results to the
FDA standard colony confirmation test on day 4 (Table 4). In
addition to the 1-day time savings, the extracellular analyte in
the sandwich ELISA technique eliminates the labor of the cell
lysis step used in the FDA standard test.
To increase the specificity of the sandwich ELISA, the use of
monoclonal antibodies against VVH was attempted. Some of
our hybridomas were weakly reactive against VVH in the an-
tibody capture ELISA but were not reactive in the sandwich
ELISA. It is possible that in the sandwich technique, the cap-
ture antibody blocked necessary VVH epitopes required by the
monoclonal antibodies for reactivity. Further attempts at pro-
ducing better hybridomas may be successful.
This sandwich ELISA technique is very useful at eliminating
the lengthy and labor-intensive standard biochemical assays for
V. vulnificus identification. Evidence of VVH production has
been found in all environmental and clinical V. vulnificus iso-
lates examined thus far. VVH is not a marker for pathogenic-
ity, since it is produced by both virulent and avirulent strains
(11, 12, 22, 37). Arguably, even presumed avirulent V. vulnifi-
cus could be hazardous to high-risk individuals (3, 34). The
extremely high mortality rate associated with V. vulnificus sep-
ticemia emphasizes the need to prevent infections from occur-
ring (20). Monitoring of oysters should include detection for
the family Vibrionaceae to reduce the risk of oyster-related
infections (13).
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